SLC2A1 and breast carcinoma: Of note, approximately half of breast cancer patients do not exhibit overexpression of GLUT1 [140]; whether increased glucose transporter activity of GLUT1 contributes to elevated glucose uptake without upregulation of GLUT1 expression in these patients remains to be determined.